Form 4 for AMBQ Ambiq Micro, Inc.
Accepted 2026-09-15 18:56:18 ET · period of report 2026-09-11 · accession 0002078454-26-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-15 18:56 | 2026-09-11+ | AMBQ | Esaka Fumihide | CEO, Dir | M - OptEx | $11.65 | +63.5K | 474.0K | +15% | +$739.6K |
| DMT | 2026-09-15 18:56 | 2026-09-11+ | AMBQ | Esaka Fumihide | CEO, Dir | S - Sale+OE | $62.70 | -63.5K | 460.5K | -12% | -$3.98M |
| DMT | 2026-09-15 18:56 | 2026-09-11+ | AMBQ | Esaka Fumihide | CEO, Dir | M - OptEx | $0.00 | -63.5K | 58.5K | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-11 | M | A | 50,000 | $12.60 | 510,460 | D | — | — | |
| 2 | Common | Common Stock | 2026-09-11 | S | D | 42,083 | $63.27 | 468,377 | D | — | — | (F1) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $62.70 to $63.70 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2026-09-11 | S | D | 7,917 | $63.86 | 460,460 | D | — | — | (F2) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $63.72 to $64.05 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2026-09-15 | M | A | 13,500 | $8.12 | 473,960 | D | — | — | (F3) The transactions occurred under a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026. |
| 5 | Common | Common Stock | 2026-09-15 | S | D | 3,785 | $59.56 | 470,175 | D | — | — | (F3) The transactions occurred under a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026. (F4) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $58.95 to $59.94 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2026-09-15 | S | D | 9,615 | $60.55 | 460,560 | D | — | — | (F3) The transactions occurred under a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026. (F5) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $59.96 to $60.80 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2026-09-15 | S | D | 100 | $61.00 | 460,460 | D | — | — | (F3) The transactions occurred under a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026. |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-09-11 | M | D | 19,007 | $0.00 | 0 | D | $12.60 · — to 2031-05-25 | 19,007 Common Stock | (F6) 1/48 of the shares subject to the option vested on June 26, 2021, and 1/48 of the shares subject to the option vested in equal monthly installments thereafter, subject to the Reporting Person's continued service. |
| 9 | Derivative | Stock Option (Right to Buy) | 2026-09-11 | M | D | 30,993 | $0.00 | 144,279 | D | $12.60 · — to 2034-07-20 | 30,993 Common Stock | (F7) 1/4 of the shares subject to the option vested on January 1, 2024, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service. |
| 10 | Derivative | Stock Option (Right to Buy) | 2026-09-15 | M | D | 13,500 | $0.00 | 58,507 | D | $8.12 · — to 2029-02-20 | 13,500 Common Stock | (F3) The transactions occurred under a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026. (F8) 1/4 of the shares subject to the option vested on February 21, 2020, and 1/48 of the shares subject to the option vested in equal monthly installments thereafter, subject to the Reporting Person's continued service. |